Top compounds associated with response to NTMT1


Feature Type Standardized
Nominal ANOVA
mRNA IPA-3 GDSC1000 pan-cancer AAC 0.082 0.01
mRNA canertinib CTRPv2 pan-cancer AAC -0.093 0.01
mRNA barasertib CTRPv2 pan-cancer AAC -0.082 0.01
mRNA TW 37 GDSC1000 pan-cancer AAC 0.081 0.01
mRNA ML203 CTRPv2 pan-cancer AAC -0.095 0.01
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.01
mRNA piperlongumine GDSC1000 pan-cancer AAC 0.08 0.01
mRNA MI-1 CTRPv2 pan-cancer AAC -0.098 0.01
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.01
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.073 0.02
Download CSV